Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A Chaidos
LACE-conditioned Autologous Stem Cell Transplantation for Relapsed or Refractory Hodgkin's Lymphoma: Treatment Outcome and Risk Factor Analysis in 67 Patients From a Single Centre
Bone Marrow Transplantation
Transplantation
Hematology
Graft Versus Lymphoma Effect After Early Relapse Following Reduced-Intensity Sibling Allogeneic Stem Cell Transplantation for Relapsed Cytotoxic Variant of Mycosis Fungoides
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Mitoxantrone-Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Relapsed/Refractory Lymphoma
Turkish Journal of Medical Sciences
Medicine
Outcomes of Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed/Refractory HIV-associated Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Infections Following Autologous Stem Cell Transplantation for Hodgkin'S Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Prognostic Factors and Long-Term Outcome of Autologous Haematopoietic Stem Cell Transplantation Following a Uniform-Modified BEAM-conditioning Regimen for Patients With Refractory or Relapsed Hodgkin Lymphoma: A Single-Center Experience
Medical Oncology
Medicine
Cancer Research
Oncology
Hematology
Autologous Stem Cell Transplantation in Elderly (>60 Years) Patients With Non-Hodgkin's Lymphoma: A Nation-Wide Analysis
Bone Marrow Transplantation
Transplantation
Hematology
Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Haploidentical Hematopoietic Stem Cell Transplantation Compared With Hla-Matched Stem Cell Transplantation for Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
